vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $51.6M, roughly 1.6× Velocity Financial, Inc.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -38.1%, a 105.4% gap on every dollar of revenue. On growth, Velocity Financial, Inc. posted the faster year-over-year revenue change (32.8% vs 20.2%). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs 24.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.

PRCT vs VEL — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.6× larger
PRCT
$83.1M
$51.6M
VEL
Growing faster (revenue YoY)
VEL
VEL
+12.6% gap
VEL
32.8%
20.2%
PRCT
Higher net margin
VEL
VEL
105.4% more per $
VEL
67.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
VEL
VEL
Annualised
VEL
32.3%
24.8%
PRCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
VEL
VEL
Revenue
$83.1M
$51.6M
Net Profit
$-31.6M
$34.8M
Gross Margin
64.9%
Operating Margin
-4.1%
97.0%
Net Margin
-38.1%
67.3%
Revenue YoY
20.2%
32.8%
Net Profit YoY
-27.9%
67.0%
EPS (diluted)
$-0.56
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
VEL
VEL
Q1 26
$83.1M
Q4 25
$76.4M
$51.6M
Q3 25
$83.3M
$49.1M
Q2 25
$79.2M
$47.6M
Q1 25
$69.2M
$37.5M
Q4 24
$68.2M
$38.9M
Q3 24
$58.4M
$35.1M
Q2 24
$53.4M
$32.4M
Net Profit
PRCT
PRCT
VEL
VEL
Q1 26
$-31.6M
Q4 25
$-29.8M
$34.8M
Q3 25
$-21.4M
$25.4M
Q2 25
$-19.6M
$26.0M
Q1 25
$-24.7M
$18.9M
Q4 24
$-18.9M
$20.8M
Q3 24
$-21.0M
$15.8M
Q2 24
$-25.6M
$14.8M
Gross Margin
PRCT
PRCT
VEL
VEL
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
VEL
VEL
Q1 26
-4.1%
Q4 25
-40.6%
97.0%
Q3 25
-27.8%
72.1%
Q2 25
-28.0%
71.3%
Q1 25
-39.7%
71.7%
Q4 24
-28.9%
82.5%
Q3 24
-38.4%
60.6%
Q2 24
-50.3%
61.3%
Net Margin
PRCT
PRCT
VEL
VEL
Q1 26
-38.1%
Q4 25
-39.1%
67.3%
Q3 25
-25.7%
51.7%
Q2 25
-24.7%
54.6%
Q1 25
-35.8%
50.4%
Q4 24
-27.6%
53.5%
Q3 24
-35.9%
45.1%
Q2 24
-48.0%
45.6%
EPS (diluted)
PRCT
PRCT
VEL
VEL
Q1 26
$-0.56
Q4 25
$-0.54
$0.90
Q3 25
$-0.38
$0.65
Q2 25
$-0.35
$0.69
Q1 25
$-0.45
$0.51
Q4 24
$-0.34
$0.56
Q3 24
$-0.40
$0.44
Q2 24
$-0.50
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
VEL
VEL
Cash + ST InvestmentsLiquidity on hand
$245.6M
$92.1M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$672.5M
Total Assets
$487.1M
$7.4B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
VEL
VEL
Q1 26
$245.6M
Q4 25
$286.5M
$92.1M
Q3 25
$294.3M
$99.0M
Q2 25
$302.7M
$79.6M
Q1 25
$316.2M
$51.7M
Q4 24
$333.7M
$49.9M
Q3 24
$196.8M
$44.1M
Q2 24
$214.1M
$47.4M
Total Debt
PRCT
PRCT
VEL
VEL
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
VEL
VEL
Q1 26
$347.7M
Q4 25
$365.9M
$672.5M
Q3 25
$380.3M
$634.3M
Q2 25
$385.8M
$597.9M
Q1 25
$389.2M
$563.2M
Q4 24
$402.2M
$516.9M
Q3 24
$241.2M
$484.6M
Q2 24
$251.8M
$471.3M
Total Assets
PRCT
PRCT
VEL
VEL
Q1 26
$487.1M
Q4 25
$508.1M
$7.4B
Q3 25
$511.5M
$7.0B
Q2 25
$513.1M
$6.5B
Q1 25
$519.4M
$6.0B
Q4 24
$534.0M
$5.5B
Q3 24
$374.1M
$5.2B
Q2 24
$374.4M
$4.9B
Debt / Equity
PRCT
PRCT
VEL
VEL
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
VEL
VEL
Operating Cash FlowLast quarter
$18.2M
Free Cash FlowOCF − Capex
$17.9M
FCF MarginFCF / Revenue
34.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$40.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
VEL
VEL
Q1 26
Q4 25
$-10.3M
$18.2M
Q3 25
$-6.6M
$11.5M
Q2 25
$-15.0M
$7.7M
Q1 25
$-17.0M
$3.5M
Q4 24
$-32.4M
$37.8M
Q3 24
$-18.8M
$-17.6M
Q2 24
$-15.7M
$11.5M
Free Cash Flow
PRCT
PRCT
VEL
VEL
Q1 26
Q4 25
$-12.2M
$17.9M
Q3 25
$-9.5M
$11.4M
Q2 25
$-17.8M
$7.6M
Q1 25
$-18.8M
$3.5M
Q4 24
$-33.6M
$37.5M
Q3 24
$-19.0M
$-17.6M
Q2 24
$-16.8M
$11.4M
FCF Margin
PRCT
PRCT
VEL
VEL
Q1 26
Q4 25
-15.9%
34.6%
Q3 25
-11.4%
23.2%
Q2 25
-22.5%
15.9%
Q1 25
-27.2%
9.2%
Q4 24
-49.2%
96.4%
Q3 24
-32.6%
-50.3%
Q2 24
-31.4%
35.1%
Capex Intensity
PRCT
PRCT
VEL
VEL
Q1 26
Q4 25
2.4%
0.5%
Q3 25
3.4%
0.1%
Q2 25
3.5%
0.2%
Q1 25
2.7%
0.2%
Q4 24
1.7%
0.7%
Q3 24
0.4%
0.2%
Q2 24
2.0%
0.3%
Cash Conversion
PRCT
PRCT
VEL
VEL
Q1 26
Q4 25
0.52×
Q3 25
0.45×
Q2 25
0.29×
Q1 25
0.19×
Q4 24
1.81×
Q3 24
-1.11×
Q2 24
0.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

Related Comparisons